Prostate Cancer - Results from #22160

Use of EORTC Target Definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: Results of the Quality Assurance Program of the Randomized Trial SAKK 09/10 - Abstract September 27, 2013

A population-based analysis of clustering identifies a strong genetic contribution to lethal prostate cancer - Abstract September 27, 2013

The European Medicines Agency review of abiraterone for the treatment of metastatic castration-resistant prostate cancer in adult men after docetaxel chemotherapy and in chemotherapy-naive disease: Summary of the scientific assessment of the Committee for September 27, 2013

Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy - Abstract September 27, 2013

Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate cancer - Abstract September 26, 2013

Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: Results from two independent nested case-control studies - Abstract September 26, 2013

Clinical characteristics and prognostic factors of prostate cancer with liver metastases - Abstract September 26, 2013

Total antioxidant intake in relation to prostate cancer incidence in the health professionals follow up study - Abstract September 26, 2013

Hybrid procedure using perineal and abdominal approaches for radical prostatocystectomy: Initial experience with 16 select cases - Abstract September 26, 2013

Mediterranean diet and prostate cancer risk and mortality in the health professionals follow-up study - Abstract September 26, 2013

Effectiveness of bone metastases treatment by sm-153 oxabifore in combination with monoclonal antibody denosumab (xgeva): First experience - Abstract September 26, 2013

New treatment options for patients with metastatic prostate cancer - Abstract September 26, 2013

Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agents - Abstract September 26, 2013

Optimal pharmacotherapeutic management of hormone-sensitive metastatic prostate cancer - Abstract September 26, 2013

Optimal bone health management strategies in patients with prostate cancer - Abstract September 25, 2013

Radical prostatectomy improves and prevents age-dependent progression of lower urinary tract symptoms - Abstract September 25, 2013

Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: An economic perspective - Abstract September 25, 2013

Do positive surgical margins predict biochemical recurrence in all patients without adjuvant therapy after radical prostatectomy? - Abstract September 25, 2013

Experience with robot-assisted laparoscopic radical prostatectomy at a secondary training hospital: Operation time, treatment outcomes, and complications with the accumulation of experience - Abstract September 25, 2013

Changes in preoperative characteristics in patients undergoing radical prostatectomy - A 16-year nationwide analysis - Abstract September 25, 2013

Page 1109 of 1434